Answers are grounded in this paper and cite their sources.
BACKGROUND: Biological aging is a fundamental driver of chronic disease, yet its role in the cause of preeclampsia and gestational hypertension remains poorly defined. METHODS: We used a multimodal framework that triangulated genetic, epidemiological, and experimental approaches to assess the associations of biological aging with preeclampsia and gestational hypertension. Publicly available human and mouse transcriptomic data were analyzed to identify shared aging- and preeclampsia-associated signatures, while the potential of nicotinic acid to alleviate aging- and preeclampsia-related features was further evaluated in experimental models. RESULTS: Two-sample Mendelian randomization demonstrated that biological age acceleration was associated with higher odds of preeclampsia (odds ratio, 1.55 [95% CI, 1.22–1.96]; P =2.67×10 − 4 ) and gestational hypertension (odds ratio, 1.56 [95% CI, 1.12–2.19]; P =0.009), while positive genetic correlations were also observed for both outcomes. In the nested case-control study, higher early pregnancy biological age acceleration was consistently associated with preeclampsia risk in both primary (odds ratio, 1.16 [95% CI, 1.01–1.35]; P =0.047) and sensitivity (odds ratio, 1.14 [95% CI, 1.03–1.29]; P =0.042) analyses, with the associations persisting after covariate adjustment and exclusion of systolic blood pressure from biological age acceleration calculation. Mouse models exhibited preeclampsia-like features accompanied by concordant alterations in biological age-related biomarkers and telomere dysfunction. These changes were partially attenuated by nicotinic acid treatment, whereas placental organoids showed limited growth responses to nicotinic acid. Complementing these phenotypic observations, transcriptomic analyses identified shared aging- and preeclampsia-associated signatures across human and mouse data sets. CONCLUSIONS: Convergent evidence links biological aging with preeclampsia and gestational hypertension, particularly biological age acceleration with preeclampsia. Experimental findings provide complementary context but do not establish a specific mechanism or therapeutic role for nicotinic acid.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: